MEDIGEN BIOTECHNOLOGY CORPORATION financial statements, including revenue, expenses, and profit
The total revenue of 3176 for the last quarter is 330.64 M TWD, and it's 24.28% lower compared to the previous quarter. The net income of Q4 24 is -113.97 M TWD.